Search

everythinglearnresearchcommunity

for

Search:↓

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Controlled microflora in animals delays immune cell maturation and affects immunity.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

The new skin model can predict how chemicals might cause skin allergies.

Acne significantly affects both physical health and mental well-being.

Hair melanocytes help the skin respond to stress and regulate hair pigmentation.

Apoptosis may play a role in feather and hair development, SF-36 is better for mental health in skin patients, a psoriasis gene is found in Caucasians, eosinophils might not be crucial for some skin allergies, and changes in atopic dermatitis could increase skin sensitivity.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

MicroRNAs could help assess and manage multiple chronic diseases.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Personalized medicine and new technologies offer promising strategies for better skin disease treatments.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Adipokines affect skin health and could be targeted for treating skin diseases.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.